{
  "zip": "77021-2040",
  "sector": "Technology",
  "longBusinessSummary": "Nexus BioPharma, Inc., a life science company, focuses on the development and commercialization of a pharmaceutical preparation to treat obesity and the symptoms of type 2 diabetes. The company is headquartered in Houston, Texas.",
  "city": "Houston",
  "phone": "346-772-0351",
  "state": "TX",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.nexusbiopharma.com",
  "maxAge": 1,
  "address1": "JLABS @ TMCx",
  "industry": "Diversified Electronics",
  "address2": "Suite J 2450 Holcombe Boulevard",
  "previousClose": 0.0012000003,
  "regularMarketOpen": 0.0075,
  "twoHundredDayAverage": 0.00961116,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0075,
  "navPrice": null,
  "averageDailyVolume10Day": 9025,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0012000003,
  "fiftyDayAverage": 0.0030454546,
  "trailingAnnualDividendRate": null,
  "open": 0.0075,
  "averageVolume10days": 9025,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.191414,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0075,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 10000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 366045,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 28035,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0075,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 10000,
  "fiftyTwoWeekHigh": 0.05,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0002,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.0075,
  "exchange": "PNK",
  "shortName": "NEXUS BIOPHARMA INC",
  "longName": "Nexus BioPharma, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "NEXS",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_340704541",
  "uuid": "383ae7eb-a2b5-36b8-a0cf-e12cfa177114",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -1.495,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 64300000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.029,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1488240000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -816641,
  "trailingEps": -0.012,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1551312000,
  "mostRecentQuarter": 1496188800,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 51195017,
  "enterpriseValue": 841340,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1331078400,
  "lastSplitFactor": "3:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0075,
  "logo_url": "https://logo.clearbit.com/nexusbiopharma.com"
}